A detailed history of Dakota Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Dakota Wealth Management holds 57,982 shares of LLY stock, worth $43.7 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
57,982
Previous 58,815 1.42%
Holding current value
$43.7 Million
Previous $53.2 Million 3.53%
% of portfolio
1.18%
Previous 1.27%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $643,192 - $799,696
-833 Reduced 1.42%
57,982 $51.4 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $264,577 - $331,799
365 Added 0.62%
58,815 $53.2 Million
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $8.77 Million - $11.7 Million
14,808 Added 33.93%
58,450 $45.5 Million
Q4 2023

Jan 30, 2024

SELL
$525.19 - $619.13 $2,625 - $3,095
-5 Reduced 0.01%
43,642 $25.4 Million
Q3 2023

Oct 23, 2023

SELL
$434.7 - $599.3 $2.3 Million - $3.16 Million
-5,281 Reduced 10.79%
43,647 $23.4 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $899,998 - $1.2 Million
2,566 Added 5.53%
48,928 $22.9 Million
Q1 2023

Apr 14, 2023

BUY
$310.63 - $364.82 $1.22 Million - $1.44 Million
3,938 Added 9.28%
46,362 $15.9 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $2.64 Million - $3.08 Million
8,215 Added 24.01%
42,424 $15.5 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $1.35 Million - $1.53 Million
-4,541 Reduced 11.72%
34,209 $11.1 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $407,503 - $478,468
-1,462 Reduced 3.64%
38,750 $12.6 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $509,042 - $632,610
-2,169 Reduced 5.12%
40,212 $11.5 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $2.8 Million - $3.48 Million
12,461 Added 41.65%
42,381 $11.7 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $4.74 Million - $5.84 Million
21,398 Added 251.09%
29,920 $6.91 Million
Q2 2021

Aug 02, 2021

BUY
$180.55 - $233.54 $214,854 - $277,912
1,190 Added 16.23%
8,522 $1.96 Million
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $103,192 - $133,588
-628 Reduced 7.89%
7,332 $1.37 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $1.04 Million - $1.37 Million
7,960 New
7,960 $1.34 Million
Q1 2020

Apr 29, 2020

SELL
$119.05 - $147.35 $242,742 - $300,446
-2,039 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$106.92 - $132.43 $3,100 - $3,840
29 Added 1.44%
2,039 $268,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $214,647 - $233,481
2,010 New
2,010 $225,000
Q2 2019

Aug 07, 2019

SELL
$110.79 - $129.32 $4.1 Million - $4.78 Million
-36,965 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$111.31 - $131.02 $3.25 Million - $3.82 Million
29,188 Added 375.31%
36,965 $345,000
Q4 2018

Jan 22, 2019

BUY
$105.9 - $118.64 $120,302 - $134,775
1,136 Added 17.11%
7,777 $844,000
Q3 2018

Nov 07, 2018

BUY
$85.86 - $107.31 $162,361 - $202,923
1,891 Added 39.81%
6,641 $712,000
Q2 2018

Aug 09, 2018

BUY
$75.7 - $86.88 $359,575 - $412,680
4,750 New
4,750 $406,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.